Cited by 536

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals

Martinez, Marilyn N., Amidon, Gordon L.·2002·The Journal of Clinical Pharmacology

Abstract

This article provides an overview of the patient‐specific and drug‐specific variables that can affect drug absorption following oral product administration. The oral absorption of any chemical entity reflects a complex spectrum of events. Factors influencing product bioavailability include drug solubility, permeability, and the rate of in vivo dissolution. In this regard, the Biopharmaceutics Classification System has proven to be an important tool for predicting compounds likely to be associated with bioavailability problems. It also helps in identifying those factors that may alter the rate and extent of drug absorption. Product bioavailability can also be markedly influenced by patient attributes such as the integrity of the gastrointestinal tract, physiological status, site of drug absorption, membrane transporters, presystemic drug metabolism (intrinsic variables), and extrinsic variables such as the effect of food or concomitant medication. Through an awareness of a drug's physicochemical properties and the physiological processes affecting drug absorption, the skilled pharmaceutical scientist can develop formulations that will maximize product availability. By appreciating the potential impact of patient physiological status, phenotype, age, gender, and lifestyle, dosing regimens can be tailored to better meet the needs of the individual patient.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/00970002042006005

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 146

  1. 10.1016/S0168-3659(99)00050-4 · DOI
  2. 10.1023/A:1018879014281 · DOI
  3. 10.1016/S0939-6411(00)00091-6 · DOI
  4. 10.1016/0163-7258(81)90040-1 · DOI
  5. 10.1023/A:1018880726035 · DOI
  6. 10.2165/00003088-199936030-00004 · DOI
  7. Sokoloski TD, 1985, Remington's Pharmaceutical Sciences., 207
  8. 10.1023/A:1018816122458 · DOI
  9. 10.1016/S0939-6411(99)00055-7 · DOI
  10. 10.1023/A:1007556711109 · DOI
  11. 10.1016/S0304-4157(97)00008-7 · DOI
  12. 10.1021/js950285r · DOI
  13. 10.1023/A:1011948703571 · DOI
  14. 10.1016/S0168-3659(99)00239-4 · DOI
  15. 10.1023/A:1016093704095 · DOI
  16. Palm K, 1999, Effect of molecular charge on intestinal epithelial drug transport, J Pharmacol Exp Therap, 291, 435
  17. 10.1023/A:1016220428705 · DOI
  18. Jackson MJ, 1987, Physiology of the Gastrointestinal Tract
  19. 10.1021/js970120d · DOI
  20. 10.1016/0169-409X(96)00009-9 · DOI
  21. 10.1023/A:1011910517200 · DOI
  22. 10.1023/A:1011958400362 · DOI
  23. Abdou HM, 1989, Dissolution, Bioavailability and Bioequivalence.
  24. 10.1023/A:1007596709657 · DOI
  25. Cussler EL, 1997, Diffusion: Mass Transfer in Fluid Systems.
  26. 10.1023/A:1018911728161 · DOI
  27. 10.1023/A:1016010207729 · DOI
  28. 10.1023/A:1018832526093 · DOI
  29. 10.1023/A:1015936426906 · DOI
  30. Dressman JB, 1997, Scientific Foundations for Regulating Drug Product Quality., 155
  31. 10.3109/10837459709022605 · DOI
  32. 10.3109/10837459809028636 · DOI
  33. 10.3109/10837459809028625 · DOI
  34. 10.1016/S0168-3659(99)00022-X · DOI
  35. Lin JH, 1999, Is the role of the small intestine in first‐pass metabolism overemphasized, Pharmacological Rev, 51, 135
  36. Lin JH, 1998, Applications and limitations of interspecies scaling and in‐vitro extrapolation in pharmacokinetics, Drug Metab Disp, 26, 1202
  37. Yeh KE, 1998, Single‐dose pharmacokinetics of indinavir and the effect of food, Antimicrob Agents Chemother, 42, 332, 10.1128/AAC.42.2.332 · DOI
  38. 10.1023/A:1018872207437 · DOI
  39. Lin JH, 1999, Effect of dexamethasone on the intestinal first‐pass metabolism of indinavir in rats: evidence of cytochrome P‐450 A and P‐glycoprotein induction, Drug Metab Disp, 27, 1187
  40. 10.1016/0163-7258(90)90036-2 · DOI
  41. 10.2165/00003088-199426020-00007 · DOI
  42. 10.3109/10408449209089881 · DOI
  43. 10.1016/S0009-9236(96)90162-9b · DOI
  44. 10.1128/AAC.38.4.842 · DOI
  45. 10.1016/0009-9236(95)90032-2 · DOI
  46. 10.1016/S0168-3659(99)00034-6 · DOI
  47. 10.1021/js980082d · DOI
  48. Davis LE, 1972, Pharmacokinetics of chloramphenicol in domesticated animals, Am J Vet Res, 33, 2259
  49. 10.1002/jps.2600810105 · DOI
  50. 10.1208/ps020104 · DOI
  51. Morgan ET, 1998, Physiological and pathophysiological regulation of cytochrome P450, Drug Metab Disp, 26, 1232
  52. Devane J, 1998, Oral drug delivery technology: addressing the solubility/ permeability paradigm, Pharm Tech, 22, 68
  53. 10.1016/S0928-0987(99)00076-7 · DOI
  54. 10.1007/978-1-4684-6036-0_17 · DOI
  55. 10.1002/jps.2600841205 · DOI
  56. 10.1023/A:1018918907670 · DOI
  57. 10.1016/0731-7085(91)80060-M · DOI
  58. 10.1038/bjc.1992.217 · DOI
  59. 10.1007/s002800050451 · DOI
  60. Monkhouse DC, 1972, Drug‐excipient interactions, Can J Pharm Sci, 7, 29
  61. 10.1016/S0378-5173(99)00176-3 · DOI
  62. 10.1016/S0014-827X(98)00101-3 · DOI
  63. 10.1023/A:1016203424278 · DOI
  64. 10.1016/0016-5085(90)91150-5 · DOI
  65. 10.1007/BF01079784 · DOI
  66. 10.1113/jphysiol.1975.sp010891 · DOI
  67. 10.1016/0016-5085(85)90589-X · DOI
  68. Welling PG, 1985, Effect of food on bioavailability of drugs, Pharm Int, 1, 14
  69. 10.1016/S0928-0987(99)00041-X · DOI
  70. 10.1053/gast.2000.18148 · DOI
  71. 10.1016/0016-5085(95)23757-7 · DOI
  72. 10.1016/0016-5085(91)70007-K · DOI
  73. 10.1023/A:1011962501270 · DOI
  74. 10.1016/S0169-409X(97)00040-9 · DOI
  75. 10.1007/BF02336686 · DOI
  76. 10.1002/jps.2600671110 · DOI
  77. 10.1023/A:1018918316253 · DOI
  78. 10.1128/AAC.39.8.1671 · DOI
  79. 10.1023/A:1018982409661 · DOI
  80. 10.1136/gut.44.4.483 · DOI
  81. 10.1023/A:1018874913372 · DOI
  82. 10.1023/A:1012183313218 · DOI
  83. 10.1023/A:1016211015926 · DOI
  84. 10.1016/S0005-2736(99)00167-4 · DOI
  85. 10.1016/S0928-0987(00)00163-9 · DOI
  86. 10.1080/00498250110060969 · DOI
  87. 10.1208/ps020320 · DOI
  88. 10.1023/A:1018982505021 · DOI
  89. Oh D‐M, 1999, Membrane Transporters as Drug Targets, 59
  90. Iseki K, 1999, Multiplicity of the H+‐dependent transport mechanism of dipeptide and anionicbeta‐lactam antibiotic ceftibuten in rat intestinal brush‐border membrane, J Pharmacol Exp Ther, 289, 66
  91. 10.1007/978-1-4613-1143-0_27 · DOI
  92. Saitoh H, 1996, The secretory intestinal transport of some beta‐lactams antibiotics and anionic compounds: a mechanism contributing to poor drug absorption, J Pharmacol Exp Ther, 278, 205
  93. 10.1016/S0928-0987(00)00178-0 · DOI
  94. 10.1016/S0169-409X(01)00183-1 · DOI
  95. 10.1042/bj2990253 · DOI
  96. 10.1006/bbrc.1996.0082 · DOI
  97. 10.1016/S0378-5173(00)00564-0 · DOI
  98. 10.1006/abbi.2000.2084 · DOI
  99. 10.1016/S0022-5193(88)80123-1 · DOI
  100. Berlioz F, 1999, Neural modulation of cephalexin intestinal absorption through the di‐ and tripeptide brush border transporter of rat jejunum in vivo, J Pharmacol Exp Ther, 288, 1037
  101. Berlioz F, 2000, Alpha(2)‐adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line, J Pharmacol Exp Ther, 294, 466
  102. Schwiebert EM, 1994, Heterotrimeric G proteins, vesicle trafficking, and CFTR Cl 2 channels, Am J Physiol, 267, C272, 10.1152/ajpcell.1994.267.1.C272 · DOI
  103. 10.1074/jbc.273.35.22627 · DOI
  104. Paris H, 1990, Alpha2‐adrenoreceptor in rat jejunum epithelial cells: characterization with [3 H]RX821002 and distribution along the villus‐crypt axis, J Pharmacol Exp Ther, 254, 888
  105. 10.1172/JCI116427 · DOI · Paper page
  106. 10.1006/bbrc.1996.0493 · DOI
  107. 10.1172/JCI117908 · DOI
  108. 10.1126/science.1065588 · DOI
  109. 10.1016/S0304-3835(00)00646-7 · DOI
  110. 10.1023/A:1011971303880 · DOI
  111. 10.1023/A:1011959828103 · DOI
  112. 10.1016/S0168-3659(99)00034-6 · DOI
  113. Dresser MJ, The MDR1, C3435T polymorphism: effects on P‐glycoprotein expression/function and clinical consequences, AAPS PharmSci, 3
  114. 10.1023/A:1012113430539 · DOI
  115. 10.1016/S0169-409X(97)00041-0 · DOI
  116. 10.1111/j.1476-5381.1996.tb15612.x · DOI
  117. 10.1093/emboj/20.20.5615 · DOI
  118. 10.1124/mol.58.3.624 · DOI
  119. 10.1023/A:1016217505990 · DOI
  120. 10.1016/S0928-0987(00)00177-9 · DOI
  121. 10.1016/S0169-409X(01)00178-8 · DOI
  122. 10.1172/JCI119439 · DOI
  123. 10.1002/bdd.2510160505 · DOI
  124. 10.2165/00003495-199141060-00009 · DOI
  125. Gottesman MM, 1993, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu Rev Biochem, 62, 386, 10.1146/annurev.bi.62.070193.002125 · DOI
  126. 10.1006/abbi.1995.1298 · DOI
  127. 10.1016/S0006-2952(97)00436-X · DOI
  128. 10.1073/pnas.94.5.2031 · DOI
  129. 10.1073/pnas.97.7.3473 · DOI
  130. 10.1016/S0006-2952(99)00377-9 · DOI
  131. 10.1016/S0304-3835(99)00355-9 · DOI
  132. Woodcock DM, 1990, Reversal of the multidrug resistance phenotype with cremophor EL, a common vehicle for water‐insoluble vitamins and drugs, Cancer Res, 50, 4199
  133. 10.1016/S0009-9236(96)80007-5 · DOI
  134. Squier TC, 1988, Lipid fluidity directly modulates the overall protein rotational mobility of the Ca‐ATPase in sarcoplamsic reticulum, J Biol Chem, 263, 9178, 10.1016/S0021-9258(19)76523-5 · DOI
  135. 10.5414/CPP38196 · DOI
  136. 10.1046/j.1432-1327.1999.00037.x · DOI
  137. 10.1016/S0959-8049(00)00450-0 · DOI
  138. 10.1007/s002100000335 · DOI
  139. Phan CT, 2001, Intestinal lipid absorption and transport, Front Biosci, 6, 299, 10.2741/Phan · DOI
  140. 10.1152/ajpendo.2001.281.5.E916 · DOI
  141. Chow SL, 1979, A dual, concentration‐dependent absorption mechanism of linoleic acid by rat jejunum in vitro, J Lipid Res, 20, 349, 10.1016/S0022-2275(20)40617-0 · DOI
  142. 10.1016/S0169-409X(01)00181-8 · DOI
  143. 10.1016/S1043-2760(01)00433-7 · DOI
  144. 10.1021/bi00460a026 · DOI
  145. 10.1016/S0021-9150(00)00456-1 · DOI
  146. 10.1126/science.290.5497.1771 · DOI

Cited by

Sorted by citations

See all 536

Metadata

Authors
Martinez, M. N., & Amidon, G. L.
Venue
The Journal of Clinical Pharmacology
Publisher
Wiley
Published
2002-06
Volume
42
Issue
6
Pages
620-643
ISSN
  • 0091-2700
  • 1552-4604
Cited by
536
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review